Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Other financing activities (as filed) (2015 - 2023)

Updated

Skye Bioscience (SKYE) posted Other financing activities of $6,026 for FY2023.

Analysis

Skye Bioscience (SKYE) Other financing activities (as filed) (2015 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -209,910.00
Mar 31, 2023 203,884.00
Sep 30, 2022 -275,537.00
Mar 31, 2022 275,537.00
Dec 31, 2021 170,606.00
Mar 31, 2015 721,069.00
API Access

Skye Bioscience Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SKYE&period=max&api_key=YOUR_API_KEY